{"adrenal disorder": 23.34, "adrenal insufficiency": 21.22, "adrenocortical insufficiency acute": 21.16, "adverse event": 6.64, "autoimmune colitis": 174.72, "autoimmune hepatitis": 26.19, "blood sodium decreased": 3.5, "blood thyroid stimulating hormone decreased": 14.18, "cholestasis": 2.59, "colitis": 113.27, "colitis ulcerative": 5.99, "conjunctivitis": 3.31, "death": 7.5, "dehydration": 3.58, "dermatitis": 3.17, "diarrhoea": 5.38, "diarrhoea haemorrhagic": 7.04, "diverticulitis": 2.23, "drug-induced liver injury": 2.28, "encephalitis": 3.31, "endocrine disorder": 55.46, "enteritis": 7.16, "enterocolitis": 84.4, "enterocolitis haemorrhagic": 51.57, "eosinophilia": 2.6, "general physical health deterioration": 3.01, "guillain-barre syndrome": 3.46, "hepatic cytolysis": 4.31, "hepatic enzyme increased": 2.9, "hepatic failure": 6.17, "hepatitis": 12.42, "hepatotoxicity": 8.27, "hospitalisation": 3.05, "hyperthyroidism": 5.47, "hypertransaminasaemia": 7.51, "hyponatraemia": 3.81, "hypophysitis": 228.13, "hypopituitarism": 101.4, "hypothalamo-pituitary disorder": 64.29, "hypothyroidism": 5.49, "immune-mediated enterocolitis": 6.16, "infusion related reaction": 2.04, "intentional product use issue": 4.49, "intestinal obstruction": 2.3, "intestinal perforation": 64.56, "large intestine perforation": 34.0, "liver disorder": 2.85, "liver function test increased": 3.99, "lymphocytic hypophysitis": 63.69, "malignant neoplasm progression": 41.07, "meningitis": 6.0, "metastases to central nervous system": 34.62, "metastases to liver": 3.05, "metastases to lung": 6.61, "metastasis": 6.46, "neoplasm": 5.64, "neuropathy peripheral": 2.6, "peritonitis": 8.06, "pleural effusion": 2.05, "pneumonitis": 6.12, "prescribed overdose": 48.38, "rash": 2.11, "rash maculo-papular": 2.82, "sepsis": 2.3, "thyroid disorder": 8.14, "thyroiditis": 6.14, "toxicity to various agents": 2.14, "transaminases increased": 2.03, "uveitis": 4.62, "vitiligo": 22.77, "weight decreased": 2.42}